Troy Lister - Jun 21, 2024 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Chief Scientific Officer
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Troy Lister
Stock symbol
VERV
Transactions as of
Jun 21, 2024
Transactions value $
$0
Form type
4
Date filed
6/25/2024, 05:05 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Award $0 +32K $0.00 32K Jun 21, 2024 Common Stock 32K $5.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 21, 2024. 25% of the shares underlying the option will vest on June 21, 2025, and the remainder are scheduled to vest in equal monthly installments thereafter until June 21, 2028.